Structural and redox behavior of oxyvita™, a zero-linked polymeric hemoglobin: Comparison with natural acellular polymeric hemoglobins

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 38, Issue 2, 2010, Pages 64-68

  Harrington, John P ^a   Orlig, Kseniya ^a   Zito, Samantha L ^a   Wollocko, Jacek ^b   Wollocko, Hanna ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b Oxyvita Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACIDS; CIRCULATORY SYSTEMS; CLINICAL APPLICATION; CONFORMATIONAL CHANGE; OXYGEN BINDING; PHYSIO-CHEMICAL PROPERTIES; REDOX BEHAVIOR; REDOX STABILITY; REDUCTION STUDIES;

CARDIOVASCULAR SYSTEM; FUNCTIONAL POLYMERS; HEMOGLOBIN; KETONES; MOLECULAR OXYGEN; ORGANIC ACIDS; PORPHYRINS; QUALITY ASSURANCE; REDUCING AGENTS; STRUCTURAL INTEGRITY; UREA;

POLYMERS;

ASCORBIC ACID; HEMOGLOBIN; POLYMER; POLYMERIZED HEMOGLOBIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCING AGENT; UREA;

ARTICLE; CHEMICAL STRUCTURE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; MOLECULAR WEIGHT; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN STRUCTURE; REDUCTION; STRUCTURE ANALYSIS;

ANIMALS; ASCORBIC ACID; BLOOD SUBSTITUTES; CATTLE; HEMOGLOBINS; NAD; OLIGOCHAETA; OXIDATION-REDUCTION; OXYGEN; POLYMERS; POWDERS; PROTEIN CONFORMATION; PROTEIN STABILITY; SOLUTIONS; UREA;

ARENICOLA; LUMBRICUS;

EID: 77949428607     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.3109/10731191003634562     Document Type: Article

References (17)

1. Harrington, J.P., Kobayashi, S., Dorman, S.C., Zito, S.L., and Hirsch, R.E. (2007). Artificial Cells, Blood Substitute and Immobilized Biotechnology, 35: 53-67.
2. Razynska, A. and Bucci, E. (1998). Zero-link Polymerization: a New Class of Polymeric Hemoglobins, in Blood Substitutes-Present and Future Perspectives, Tuschida, E. (ed), Elsevier Science, Switzerland, pp. 265-279.
3. Bucci, E., Kwansa, H., Koehler, R.C. and Matheson, B. (2007). Artificial Cells, Blood Substitutes and Immobilized Biotechnology 35: 11-18.
4. OXYVITA. Hb preparation based upon patent formulation [US Patent].
5. Matheson, B., Razynska, A., Kwansa, H. and Bucci, E. (2000). Journal of Laboratory and Clinical Investigation 135: 459-464.
6. Bucci, E., Razynska, A., Kwansa, H., Matheson-Urbaitis, B.,O'Hearne, J.A., Utalowski, J.A. and Koehler, R.C. (1996). Journal of Laboratory and Clinical Medicine 128: 146-153.
7. Jia, Y. and Alayash, A.I. (2009). Biochimica et Biophysica Acta, Proteins and Proteomics 1794: 1234-1242.
8. Matheson, B., Kwansa, H.E., Rebel, A., Mito, T., Koehler, R.C. and Bucci, E. (2002). Journal of Applied Physiology 93: 1479-1486.
9. Harrington, J.P., Pandofelli, E.R. and Herskovits, T.T. (1973). Biochimica et Biophysica Acta 328: 71-83.
10. DiIori, E. (1981). Methods in Enzymlogy 76: 47-72.
11. Harrington, J.P. (1998). Comparative Biochemisty and Physiology B 119B: 305-309.
12. Rachmilewitz, E. A. (1974). Seminar in Hematology 11: 441-462.
13. Alayash A.I. and Cashon, R.E. (1995). Molecular Medicine Today 1: 122-127.
14. Faivre, B., Menu, P., Labrude, P. and Vigernon, C. (1998). Artificial Cells, Blood Substitute and Immobilized Biotechnology 26: 17-26.
15. Harrington, J.P., Gonzalez, Y. and Hirsch, R.E. (2000). Artificial Cells, Blood Substitute and Immobilized Biotechnology 28: 477-492.
16. Cooper, C.E., Silaghi-Dumitrescu, R., Rukengwa, M., Alayash, A.I. and Buehler, P.W. (2008). Biochimica et Biophysica Acta 1784: 1415-1420.
17. Dorman, S.C., Kenny, C., Miller, L., Hirsch, R.E. and Harrington, J.P. (2002). Artificial Cells, Blood Substitute and Immobilized Biotechnology 30: 43-56.